Rapaport S I, Zivelin A, Minow R A, Hunter C S, Donnelly K
Department of Medicine, University of California, San Diego, La Jolla.
Am J Clin Pathol. 1992 Jan;97(1):84-91. doi: 10.1093/ajcp/97.1.84.
Two patients exposed during surgery to bovine thrombin developed antibodies reacting with both bovine and human thrombin and Factor V. Their thrombin times were markedly prolonged with bovine thrombin and modestly prolonged with human thrombin. High titer anti-bovine Factor V created diagnostic confusion in one patient by neutralizing bovine Factor V in a prothrombin assay substrate. Although weaker, antibody activity against human Factor V led to postoperative factor V deficiency in both patients. Such cross-reacting antibodies, recognizable by their higher titer against bovine than human Factor V, should be suspected when a patient surgically exposed to bovine thrombin develops a Factor V anticoagulant after operation. Crossed immunoelectrophoresis of adsorbed bovine plasma with each patient's plasma as antibody revealed many precipitin arcs indicative of immunization of the patients to additional proteins in a commercial thrombin preparation.
两名在手术中接触牛凝血酶的患者产生了与牛和人凝血酶及因子V发生反应的抗体。他们的凝血酶时间在用牛凝血酶时显著延长,用人凝血酶时适度延长。高滴度抗牛因子V在一名患者的凝血酶原检测底物中中和牛因子V,造成诊断混淆。虽然针对人因子V的抗体活性较弱,但导致了两名患者术后因子V缺乏。当手术中接触牛凝血酶的患者术后出现因子V抗凝物时,应怀疑存在这种对牛因子V滴度高于人因子V的交叉反应抗体。用每位患者的血浆作为抗体对吸附的牛血浆进行交叉免疫电泳,发现许多沉淀弧,表明患者对商业凝血酶制剂中的其他蛋白质发生了免疫反应。